LMO2 and acute lymphoblastic leukemia: Examples are mutations of T-ALL-related oncogenes/onco-suppressors, such as NOTCH1, FBXW7, PTEN, and RPL10; deletions of CDKN2AB; and translocations in T-related transcription factors, such as TAL1, LMO1, LMO2, MYB, NKX2.1, and TLX1 [11,31,33,34,35].